WO2013067607A1 - Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée - Google Patents

Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée Download PDF

Info

Publication number
WO2013067607A1
WO2013067607A1 PCT/BR2011/000413 BR2011000413W WO2013067607A1 WO 2013067607 A1 WO2013067607 A1 WO 2013067607A1 BR 2011000413 W BR2011000413 W BR 2011000413W WO 2013067607 A1 WO2013067607 A1 WO 2013067607A1
Authority
WO
WIPO (PCT)
Prior art keywords
botulinum toxin
skin
drug
effect
application
Prior art date
Application number
PCT/BR2011/000413
Other languages
English (en)
Portuguese (pt)
Inventor
Ivo STERNICK
Original Assignee
Sternick Ivo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sternick Ivo filed Critical Sternick Ivo
Priority to PCT/BR2011/000413 priority Critical patent/WO2013067607A1/fr
Publication of WO2013067607A1 publication Critical patent/WO2013067607A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
    • A61M5/427—Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937—Visible markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/10—Computer-aided planning, simulation or modelling of surgical operations

Definitions

  • Single molds simulating the skin effect of intramuscular injection of attenuated botulinum toxin.
  • the present utility model patent relates to single thickness laminar devices with circumferential shapes, with radius measurements that vary respectively with the cutaneous effect of different dosages of botulinum toxin type A. It also has a small perforation-like central hole to serve as injection site locator and marker. These small discs simulating the cutaneous effect of intramuscular application of botulinum toxin are used to help identify and position the injection site of this drug. According to the position of the disc, the approximate range of skin effect resulting from the applied dose is shown. The device is placed on the patient's skin in the desired treatment area. From the perforation of the central point of the disc, the injection point will be marked, simulating very closely the effect of radiant diffusion of the drug. .
  • botulinum toxin type A for aesthetic purposes on the face are performed in variable ways through the determination of application points and amount of dose to be applied at each point, according to the practical experiences of several physicians, who publish their techniques in scientific articles in specialized journals, basing their claims on approximate diffusions of the drug. Labels provided by the labs supplement the information and do not offer ancillary devices.
  • the present use model proposes a more specific pattern of application which, in addition to determining the range of drug doses, provides a preview of the effect. By simply placing the laminar devices on the skin, one can simply mark Use a pencil or pen appropriate to the area of the device and use it next to the marking to trace the next diameter of application.
  • botulinum toxin type A we applied botulinum toxin type A at specific doses and observed the format and dimensions of the results. From this we averaged the results and put them in the mold formats. That is why we emphasize that the dimensions are approximate.
  • botulinum toxin type A has been tested on several people of different sex, race and size, with only minor variations. Due to this information we find it valid even if slight variations in range exist that make use of the disc. At Differences will not contribute to the failure of the application causing error to occur, as the difference will be only a few millimeters.
  • Fig. 1 shows them from the front.
  • Fig.2 shows them sideways
  • Fig. 3 shows the application point and the simulation of the area to be reached.
  • Fig. 5 illustrates the shape of botulinum toxin applied with small 3mm ridges.
  • botulinum toxin type A There are already application templates for botulinum toxin type A registered, but they are configured as a single slide with markings on it - Pub. No .: US 2005/0148935. We believe we differentiate our molds mainly by the loose aspect of the units that facilitates the handling for the application, provides a more individualized application, paying attention to the details of anatomical variations of each individual; be easily included in the packaging of the drug itself, and enable greater stimulation and facilitation for the untried applicator

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention concerne des dispositifs lamellaires séparés de forme circulaire, de fine épaisseur et de petit diamètre, variant selon le dosage du médicament utilisé. Ils présentent une dimension correspondant à l'effet de l'application du médicament dans la peau sus-jacente au muscle subissant l'injection. Un orifice central dans le dispositif permet le marquage et l'identification du point idéal d'injection. Lors d'une mise en place sur la peau, il imite la zone appelée à subir l'effet conséquent à une paralysie musculaire. Ainsi, par contraste avec l'utilisation de modèles lamellaires pré-établis pour applications locales, l'applicateur offre une aide plus pratique dans la schématisation des injections nécessaires pour atteindre le résultat souhaité suite à l'utilisation de toxine botulique atténuée, principalement en ce qui concerne la région frontale du visage, l'une des zones les plus sollicitées à des fins de traitement esthétique.
PCT/BR2011/000413 2011-11-08 2011-11-08 Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée WO2013067607A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/BR2011/000413 WO2013067607A1 (fr) 2011-11-08 2011-11-08 Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2011/000413 WO2013067607A1 (fr) 2011-11-08 2011-11-08 Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée

Publications (1)

Publication Number Publication Date
WO2013067607A1 true WO2013067607A1 (fr) 2013-05-16

Family

ID=48288390

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2011/000413 WO2013067607A1 (fr) 2011-11-08 2011-11-08 Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée

Country Status (1)

Country Link
WO (1) WO2013067607A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148935A1 (en) * 2003-12-29 2005-07-07 Rozalina Dimitrova Botulinum toxin injection guide
BRPI0412655A (pt) * 2003-07-15 2006-09-26 Allergan Inc dispositivo para auxiliar a terapia de hiperhidrose
BRMU8903121U2 (pt) * 2009-09-18 2012-01-17 Ivo Sternick moldes avulsos simuladores do efeito cutáneo da injeção intramuscular de toxina botulìnica atenuada

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412655A (pt) * 2003-07-15 2006-09-26 Allergan Inc dispositivo para auxiliar a terapia de hiperhidrose
US20050148935A1 (en) * 2003-12-29 2005-07-07 Rozalina Dimitrova Botulinum toxin injection guide
BRMU8903121U2 (pt) * 2009-09-18 2012-01-17 Ivo Sternick moldes avulsos simuladores do efeito cutáneo da injeção intramuscular de toxina botulìnica atenuada

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GRIMALT R. ET AL.: "Multi-injection plate for botulinum toxin application in the treatment of axillary,hyperhidrosis", DERMATOLOGIC SURGERY, vol. 27, no. 6, 20 December 2001 (2001-12-20), pages 543 - 544, XP002324095, DOI: doi:10.1046/j.1524-4725.2001.01010.x *

Similar Documents

Publication Publication Date Title
BR112015008326A2 (pt) método relacionado com a granularidade de presença com realidade ampliada
BR112015007836A2 (pt) dispositivo de computação configurado para fornecer dimensões faciais de um indivíduo com base em ao menos duas imagens bidimensionais obtidas com uma câmera, sistema para coletar dados da face de um indivíduo, método para coletar dados tridimensionais da face de um indivíduo, método para fornecer uma interface para o paciente a um indivíduo, e programa de computador
BR112015015230A2 (pt) sistema e processo para abordar generalização em uma rede neural
BR112014032509A2 (pt) controle de fluxo de fluidos usando canais
Cattermole et al. Too tall for the tape: the weight of schoolchildren who do not fit the Broselow tape
Lee et al. Observed score equating for mixed-format tests using a simple-structure multidimensional IRT framework
BRMU8903121U2 (pt) moldes avulsos simuladores do efeito cutáneo da injeção intramuscular de toxina botulìnica atenuada
Majumder et al. Prevalence and sex distribution of temporomandibular disorder and their association with anxiety and depression in Indian medical university students
WO2013067607A1 (fr) Modèles séparés simulant l'effet cutané de l'injection intramusculaire de toxine botulique atténuée
Jain Implementation of marker proteins using standardised effect
Hitchcock et al. Best learning practices for Internet treatments.
BR112015014557A2 (pt) método, aparelho e sistema para indexar conteúdo com base na informação do tempo
Matthews Self-concept and the gifted.
Kudrina et al. Information guidance for the development of targeted training of medical specialists
Lee Analysis on the Characteristics of National Assessment of Educational Achievement (NAEA) Items for the Science Subject: With a Focus on Classical Mechanics
Gorayeb et al. Treatment programs including botulinum toxin, treatment goals, and goal achievment for poststroke spasticity: Does time matter?
Kim et al. Stress, interpersonal competence and health promotion behavior of health allied undergraduate students
Utama Analysis Of Personification Expression Used In The Blink 182 Songs
Sukmana et al. The Effect of Occupatioal Therapy on Social Skill in Schizofrenia with Social Isolation
Kennedy et al. Assessing Brief Changes in Adolescent's Mood: Outcomes and lessons learned from evaluating complementary and alternative medicine therapy integration into the multi-disciplinary treatment of adolescents in a psychiatric hospital setting
Thakur Effect of Yoga to measure the Explosive Muscle Power in Visually Impairment School Students
Ho et al. Inpatient and Outpatient Treatment Programs for Substance Use Disorder: A Review of Clinical Effectiveness and Guidelines [Internet]
Liu et al. Application of U-fixed red wax mask in radiotherapy
Kumar et al. Drug utilization in clinical conditions: an update on its essentials.
Dewi et al. Prevalence and risk factors of obesity in primary school in urban and rural areas

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11875312

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11875312

Country of ref document: EP

Kind code of ref document: A1